发明名称 20−HYDROXYEICOSATETRAENOIC ACID PRODUCTION INHIBITORS
摘要 Hydroxyformamidine compounds represented by the following general formula or pharmaceutically acceptable salts thereof: wherein R<sp>1</sp> represents substituted morpholino, substituted piperidino, piperazin−1−yl, substituted piperazin−1−yl, thiomorpholin−1−yl, perhydroazepin−1−yl, perhydroazocin−1−yl, tetrahydropyridin−1−yl, pyrrolin−1−yl, etc.; X represents nitrogen or CR<sp>5</sp>; and R<sp>2</sp> to R<sp>5</sp> are the same or different and each represents hydrogen, C<sb>1−4</sb> alkyl, C<sb>1−4</sb> alkoxy, trifluoromethyl or halogeno. Drugs inhibiting 20−HETE synthase relating to contraction/dilation of microvessels, induction of cell proliferation, etc. in main organs such as kidney and cerebral vessels.
申请公布号 WO02088071(A1) 申请公布日期 2002.11.07
申请号 WO2002JP04252 申请日期 2002.04.26
申请人 TAISHO PHARMACEUTICAL CO., LTD.;SATO, MASAKAZU;MIYATA, NORIYUKI;ISHII, TAKAAKI;MATSUNAGA, YUKO;AMADA, HIDEAKI 发明人 SATO, MASAKAZU;MIYATA, NORIYUKI;ISHII, TAKAAKI;MATSUNAGA, YUKO;AMADA, HIDEAKI
分类号 A61K31/136;A61K31/402;A61K31/4418;A61K31/451;A61K31/4525;A61K31/47;A61K31/495;A61K31/496;A61K31/5375;A61K31/54;A61K31/55;A61P9/00;A61P9/10;A61P13/12;A61P43/00;C07C259/14;C07D207/20;C07D211/22;C07D211/46;C07D211/60;C07D211/62;C07D211/70;C07D213/74;C07D213/75;C07D217/04;C07D295/13;C07D295/135;C07D295/15;C07D401/04;C07D491/10;C07D491/113;(IPC1-7):C07C259/14;C07D215/06;C07D241/04;C07D265/30;C07D295/12;A61K31/441;A61K31/452;A61K31/537 主分类号 A61K31/136
代理机构 代理人
主权项
地址